Answers are grounded in this paper and cite their sources.
Investigates neuroinflammation caused by P.g-OMVs in a mouse model, suggesting new therapeutic targets.
Porphyromonas gingivalis (P.g), a key periodontal pathogen, is implicated in Alzheimer’s disease (AD). Given that mitochondrial dysfunction is a common event happened in neurodegenerative diseases, mitochondria-associated endoplasmic reticulum (ER) membranes (MAMs) play a potential role in AD pathology. This study aimed to investigate the impact of P.g derived outer membrane vesicles (P.g-OMVs) on neuroinflammation in the onset and progression of AD, and to elucidate the underlying mechanism. Eight-week-old male C57BL/6 mice received bilateral gingival injections of P.g-OMVs (4 × 10⁸ particles) 3 times weekly for 8 weeks to assess cognitive impairment and neuroinflammation. RNA-seq identified differentially expressed genes (DEGs) and enriched pathway in brain tissues. In vitro, HT22 cells were treated with P.g-OMVs (5 µg/mL), and the expressions of inflammatory cytokines, transglutaminase 2 (TGM2) and ferroptosis markers were quantified. MAM formation and mitochondrial function regulated by TGM2, including mitochondrial Ca2+ accumulation and membrane potential, were assessed, which further elucidated after knocking down TGM2 by siRNA. P.g-OMVs induced significant cognitive impairment and neurodegeneration in mice, evidenced by escape latency in the MWM (p < 0.001) and accumulation of amyloid β plaques and hyperphosphorylated tau. RNA-seq highlighted DEGs enriched in mitochondrial pathways, notably targeting TGM2. In vitro, P.g-OMVs triggered inflammation evidenced by increased pro-inflammatory cytokines (IL-1β, IL-17, etc.) and reduced levels of IL-10 (p < 0.05), and led to the upregulation of TGM2 (p < 0.05). Crucially, co-localization of mitochondria and ER suggested that P.g-OMVs promoted MAM formation in neurons, accompanied by aberrant mitochondrial Ca2+ levels and membrane potential. Additionally, altered expressions of ferroptotic markers were observed, including increased level of ACSL4 (p < 0.01) and decreased levels of GPX4 and xCT (p < 0.01). TGM2 knockdown reversed the inflammation, ferroptosis, mitochondrial dysfunction and MAM formation. Our findings demonstrate that P.g-OMVs drive neuroinflammation and neuronal ferroptosis through a MAMs-associated mechanism. TGM2 acts as a key mediator, promoting MAM formation and subsequent mitochondrial dysfunction. These findings highlight TGM2 represents a potential therapeutic target for neuroinflammatory conditions linked to oral pathogens.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: